South African Trial Shows Effectiveness of New ARV Drug
A new antiretroviral drug regimen has been given the go-ahead by the World Health Organisation. Preliminary results from studies that include an ongoing trial in South Africa show that dolutegravir is an effective and well-tolerated antiretroviral drug. The results are important because the Johannesburg trial includes a population representative of the real-world populations being treated for HIV across lower- and middle-income countries.
(File photo)
InFocus
-
About 1.7 million people worldwide became newly infected with HIV in 2018, a 16% decline since 2010, a new report by UNAIDS says. The report was launched at a community event in ... Read more »